Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency

被引:79
作者
Sverrisdóttir, YB
Elam, M
Herlitz, H
Bengtsson, BÅ
Johannsson, G
机构
[1] Sahlgrens Univ Hosp, Inst Clin Neurosci, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Nephrol, S-41345 Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Res Ctr Endocrinol & Metab, S-41345 Gothenburg, Sweden
关键词
D O I
10.1210/jc.83.6.1881
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Perturbations in the sympathetic nervous system may be anticipated in adults with hypopituitarism and untreated GH deficiency, because the syndrome is associated with both peripheral and central factors known to modulate sympathetic traffic. The higher prevalence of hypertension and increased cardiovascular morbidity/mortality reported in GH-deficient patients may suggest increased activity of the sympathetic nervous system. We recorded muscle sympathetic nerve activity (MSNA) in 10 hypopituitary adults with adequate hormonal replacement therapy except GH and in 10 healthy controls matched for age, gender, and body mass index to test whether hormonal aberrations in hypopituitarism and untreated GH deficiency are associated with an increase in sympathetic nerve traffic. Blood samples for insulin-like growth factor I, free T-4, and TSH were taken after an overnight fast, followed by an oral glucose tolerance test. Direct intraneural recordings of MSNA were performed with a tungsten microelectrode from the peroneal nerve. The hypopituitary subjects had markedly increased MSNA (54 +/- 4 bursts/min vs. 34 +/- 4 in controls; P < 0.002), which was not related to abdominal obesity or altered glucose metabolism. When assessed for the whole study group, MSNA was inversely correlated to serum insulin-like growth factor I(r = -0.59; P < 0.006) and TSH (r = -0.46; P < 0.04). MSNA was positively correlated to diastolic blood pressure (r = 0.80; P < 0.0005) in patients, but not in controls. The intense sympathetic discharge is suggested to be of central origin and may be an important underlying mechanism for the secondary hypertension and increased cardiovascular morbidity/mortality in this patient group.
引用
收藏
页码:1881 / 1885
页数:5
相关论文
共 49 条
[1]   EFFECT OF ENERGY-RESTRICTED DIET ON SYMPATHETIC MUSCLE NERVE ACTIVITY IN OBESE WOMEN [J].
ANDERSSON, B ;
ELAM, M ;
WALLIN, BG ;
BJORNTORP, P ;
ANDERSSON, OK .
HYPERTENSION, 1991, 18 (06) :783-789
[2]  
BENGTSSON BA, 1995, ENDOCRINOL METAB SB, V2, P29
[3]   Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency - A double-blind, placebo-controlled study [J].
Boger, RH ;
Skamira, C ;
BodeBoger, SM ;
Brabant, G ;
Muhlen, AVZ ;
Frolich, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2706-2713
[4]   Increased cerebrovascular mortality in patients with hypopituitarism [J].
Bulow, B ;
Hagmar, L ;
Mikoczy, Z ;
Nordstrom, CH ;
Erfurth, EM .
CLINICAL ENDOCRINOLOGY, 1997, 46 (01) :75-81
[5]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[6]   GROWTH-HORMONE REGULATION OF GROWTH HORMONE-RELEASING HORMONE GENE-EXPRESSION [J].
COLONNA, VD ;
CATTANEO, E ;
COCCHI, D ;
MULLER, EE ;
MAGGI, A .
PEPTIDES, 1988, 9 (05) :985-988
[7]   SYMPATHETIC OVERACTIVITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
CONVERSE, RL ;
JACOBSEN, TN ;
TOTO, RD ;
JOST, CMT ;
COSENTINO, F ;
FOUADTARAZI, F ;
VICTOR, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1912-1918
[8]   EVIDENCE FOR A ROLE OF ALPHA-ADRENERGIC MECHANISMS IN REGULATION OF EPISODIC GROWTH-HORMONE SECRETION IN RAT [J].
DURAND, D ;
MARTIN, JB ;
BRAZEAU, P .
ENDOCRINOLOGY, 1977, 100 (03) :722-728
[9]   IS SYMPATHETIC NEURAL HYPERACTIVITY IN CHRONIC HEART-FAILURE AFFECTED BY HEART-TRANSPLANTATION [J].
ELAM, M ;
CASALE, R ;
LAROVERE, MT ;
MORTARA, A ;
TAVAZZI, L .
EUROPEAN HEART JOURNAL, 1993, 14 (04) :521-525
[10]  
FLINKENSTEIN JW, 1972, J CLIN ENDOCR METAB, V35, P665